Inhibitex Inc. (Nasdaq: INHX) will be acquired by Bristol-Myers Squibb Co. (NYSE: BMY) for approximately $2.5 billion in cash. Shares of Inhibitex more than doubled by leaping $13.90 to $23.76 while Bristol-Myers stock slipped 37 cents to $33.85.
Bristol-Myers To Pay $2.5 Billion For Inhibitex
January 09, 2012 at 13:18 PM EST
